These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24831654)

  • 1. Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients.
    Marotti SB; Barras M; Kirkpatrick C
    Ther Drug Monit; 2015 Feb; 37(1):33-9. PubMed ID: 24831654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
    Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
    Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome.
    Joncas SX; Poirier P; Ardilouze JL; Carrier N; Fayad T; Farand P
    Obesity (Silver Spring); 2013 Sep; 21(9):1753-8. PubMed ID: 23404940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study.
    Bauer SR; Ou NN; Dreesman BJ; Armon JJ; Anderson JA; Cha SS; Oyen LJ
    Mayo Clin Proc; 2009 Dec; 84(12):1073-8. PubMed ID: 19955244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a Calculation-Free Weight-Based Unfractionated Heparin Nomogram With Anti-Xa Level Monitoring Compared With Activated Partial Thromboplastin Time.
    Kindelin NM; Anthes AM; Providence SM; Zhao X; Aspinall SL
    Ann Pharmacother; 2021 May; 55(5):575-583. PubMed ID: 32964730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two nomograms of unfractionated heparin in patients with acute coronary syndrome.
    Modares Mosadegh M; Sadr Bafghi SM
    Acta Med Iran; 2013 Mar; 51(2):87-93. PubMed ID: 23585314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes.
    Melloni C; Alexander KP; Chen AY; Newby LK; Roe MT; Allen LaPointe NM; Pollack CV; Gibler WB; Ohman EM; Peterson ED;
    Am Heart J; 2008 Aug; 156(2):209-15. PubMed ID: 18657648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of unfractionated heparin using activated partial thromboplastin time: an assessment of the current nomogram and analysis according to age.
    Kim JS; Lee HJ; Sung JD; Kim HJ; Lee SY; Kim JS
    Clin Appl Thromb Hemost; 2014 Oct; 20(7):723-8. PubMed ID: 23615295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of unfractionated heparin in critically ill patients.
    Aarab R; van Es J; de Pont AC; Vroom MB; Middeldorp S
    Neth J Med; 2013 Nov; 71(9):466-71. PubMed ID: 24218420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients.
    Riney JN; Hollands JM; Smith JR; Deal EN
    Ann Pharmacother; 2010; 44(7-8):1141-51. PubMed ID: 20587743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
    Ansara AJ; Arif S; Warhurst RD
    Ann Pharmacother; 2009 Jan; 43(1):9-18. PubMed ID: 19126826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity.
    Barletta JF; DeYoung JL; McAllen K; Baker R; Pendleton K
    Surg Obes Relat Dis; 2008; 4(6):748-53. PubMed ID: 18586569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview.
    Bernardi E; Piccioli A; Oliboni G; Zuin R; Girolami A; Prandoni P
    Thromb Haemost; 2000 Jul; 84(1):22-6. PubMed ID: 10928464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias.
    Roswell RO; Greet B; Shah S; Bernard S; Milin A; Lobach I; Guo Y; Radford MJ; Berger JS
    J Thromb Thrombolysis; 2016 Aug; 42(2):179-85. PubMed ID: 26951166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a bolus of intravenous heparin while initiating heparin therapy in anticoagulation following transient ischemic attack or stroke does not lead to increased morbidity or mortality.
    Toth C
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):463-8. PubMed ID: 12851532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke.
    Toth C; Voll C
    Stroke; 2002 Mar; 33(3):670-4. PubMed ID: 11872885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.
    Raschke RA; Reilly BM; Guidry JR; Fontana JR; Srinivas S
    Ann Intern Med; 1993 Nov; 119(9):874-81. PubMed ID: 8214998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of as Needed Heparin Boluses on Supratherapeutic Activated Partial Thromboplastin Time in Patients Managed With Extracorporeal Membrane Oxygenation.
    Corcoran DM; Kovacevic MP; Dell'Orfano H; Sylvester KW; Connors JM
    Crit Pathw Cardiol; 2024 Sep; 23(3):159-165. PubMed ID: 38285539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.